{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Seventy million Americans will have turned 65 by 2030, and doctors and nurses are struggling to deal with an explosive growth in high-risk older patients.", "headline": {"seo": "Preparing to Care for an Aging Population", "main": "Preparing More Care of Elderly", "kicker": "The New Landscape", "print_headline": "Preparing More Care Of Elderly", "content_kicker": "The New Landscape"}, "abstract": null, "print_page": "5", "word_count": "1719", "_id": "5417f6ed79881018c3790329", "snippet": "Seventy million Americans will have turned 65 by 2030, and doctors and nurses are struggling to deal with an explosive growth in high-risk older patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/06/29/health/29geri.html", "multimedia": [{"subtype": "xlarge", "url": "images/2010/06/29/science/jpGERI/jpGERI-articleLarge.jpg", "height": 359, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2010/06/29/science/jpGERI/jpGERI-articleLarge.jpg", "xlargeheight": "359"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2010/06/29/science/jpGERI/jpGERI-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/06/29/science/jpGERI/jpGERI-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Reform and Reorganization", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Elderly", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Doctors", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Elder Care", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2010-06-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "An Italian doctor suggests widening veins to ease symptoms of multiple sclerosis, and his theory has caught on with patients and some doctors, too.", "headline": {"main": "From M.S. Patients, Outcry for Unproved  Treatment", "sub": "Vein-Opening Procedure Attracts Adherents, Though Theory Is Unproved;", "print_headline": "From M.S. Patients, Outcry for Surgery"}, "abstract": null, "print_page": "1", "word_count": "2522", "_id": "5417f71f79881018c379032d", "snippet": "An Italian doctor suggests widening veins to ease symptoms of multiple sclerosis, and his theory has caught on with patients and some doctors, too.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/06/29/health/29vein.html", "multimedia": [{"subtype": "xlarge", "url": "images/2010/06/29/science/VEIN1/VEIN1-articleLarge.jpg", "height": 330, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2010/06/29/science/VEIN1/VEIN1-articleLarge.jpg", "xlargeheight": "330"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2010/06/29/science/VEIN1/VEIN1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/06/29/science/VEIN1/VEIN1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Multiple Sclerosis", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Denise", "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2010-06-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Global pharmaceutical companies are ranked on how readily they make their products available to the world\u2019s poor.", "headline": {"main": "The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor", "kicker": "Global Update", "print_headline": "THE DRUG INDUSTRY: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor", "content_kicker": "Global Update"}, "abstract": null, "print_page": "6", "word_count": "236", "_id": "5417f68e79881018c379031e", "snippet": "Global pharmaceutical companies are ranked on how readily they make their products available to the world\u2019s poor.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/06/29/health/29glob.html", "multimedia": [{"subtype": "xlarge", "url": "images/2010/06/29/science/GLOBA/GLOBA-articleLarge.jpg", "height": 315, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2010/06/29/science/GLOBA/GLOBA-articleLarge.jpg", "xlargeheight": "315"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2010/06/29/science/GLOBA/GLOBA-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/06/29/science/GLOBA/GLOBA-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Novo Nordisk", "is_major": "N", "rank": "11", "name": "organizations"}, {"value": "Bayer AG", "is_major": "N", "rank": "12", "name": "organizations"}, {"value": "Third World and Developing Countries", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Generic Brands and Products", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "GlaxoSmithKline PLC", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Merck & Company Inc", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Novartis AG", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Gilead Sciences Incorporated", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "10", "name": "organizations"}], "byline": {"contributor": "", "person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2010-06-29T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 3, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}